An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)
More specific conditions that are subtypes of Dacarbazine in the MeSH hierarchy.
4 drugs (3 approved, 1 experimental)
Other trials (5)